Login / Signup

Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry.

Jasmin Beate Kuemmerle-DeschnerTilmann KallinichJoerg Christoph HenesBirgit Kortus-GötzePrasad T OommenJuergen RechTobias KrickauFrank Weller-HeinemannGerd HorneffAleš JandaIvan FoeldvariCatharina SchuetzFrank DresslerMichael BorteMarkus HufnagelFlorian MeierMichael FieneIoana AndreicaJulia Weber-ArdenNorbert Blank
Published in: RMD open (2024)
Data from this analysis confirm the long-term safety and effectiveness of canakinumab for the treatment of CAPS, FMF, TRAPS and MKD/HIDS.
Keyphrases
  • randomized controlled trial
  • systematic review
  • electronic health record
  • machine learning
  • data analysis
  • deep learning
  • artificial intelligence
  • replacement therapy